{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:11:39Z","timestamp":1794672699774,"version":"4.9.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND:<\/jats:title>\n            <jats:p>Macrophage-derived extracellular vesicles with microRNAs can cause and develop colon cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To investigate M2 macrophage-derived extracellular vesicles and colon cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>A prospective and experimental study of M2 macrophage-derived extracellular vesicles in colon cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>This study was completed at the Fourth Hospital of Hebei Medical University.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Patients with colon cancer who had undergone surgical resection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MAIN OUTCOME MEASURES:<\/jats:title>\n            <jats:p>Suppressor of cytokine signaling 3, miR-501-3p, SET domain containing 7, and DNA methyltransferase 1 were measured in colon cancer samples. Multiple experiments determined suppressor of cytokine signaling 3, miR-501-3p, SET domain containing 7, and DNA methyltransferase 1 binding affinity. M2 macrophages were cultivated from M0 macrophages isolated from peripheral blood mononuclear cells of a healthy donor and polarized to produce extracellular vesicles. Gain- or loss-of-function tests using colon cancer cells and M2 macrophage-derived extracellular vesicles revealed cell biological processes. Finally, animal models were created to test how miR-501-3p from M2-extracellular vesicles affects tumor growth via the SET domain containing 7\/DNA methyltransferase 1\/suppressor of cytokine signaling 3.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Colon cancer increased miR-501-3p and DNA methyltransferase 1 and downregulated suppressor of cytokine signaling 3 and SET domain containing 7. miR-151-3p inhibited SET domain containing 7, upregulating DNA methyltransferase 1. Increased promoter methylation by DNA methyltransferase 1 decreased suppressor of cytokine signaling 3 expression. M2-EVs with miR-501-3p regulated the SET domain containing 7\/DNA methyltransferase 1\/suppressor of cytokine signaling 3 axis to induce apoptosis and colon cancer cell growth, invasion, and migration. M2-EV\u2013delivered miR-501-3p also regulated the SET domain containing 7\/DNA methyltransferase 1\/suppressor of cytokine signaling 3 axis to promote tumor growth in animals.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>LIMITATIONS:<\/jats:title>\n            <jats:p>Further research is needed in clinical application of M2 macrophage-derived extracellular vesicles containing miR-501-3p as a biomarker of colon cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>M2 macrophage-derived extracellular vesicles with miR-501-3p regulate the SET domain containing 7\/DNA methyltransferase 1\/suppressor of cytokine signaling 3 axis to promote colon cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>LAS VES\u00cdCULAS EXTRACELULARES DERIVADAS DE MACR\u00d3FAGOS M2 QUE CONTIENEN MICROARN-501-3P PROMUEVEN LA PROGRESI\u00d3N DEL C\u00c1NCER DE COLON A TRAV\u00c9S DEL EJE SETD7\/DNMT1\/SOCS3<\/jats:title>\n            <jats:p>\n                                 <jats:bold>ANTECEDENTES:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Las ves\u00edculas extracelulares derivadas de macr\u00f3fagos con microARN pueden causar y desarrollar c\u00e1ncer de colon.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>OBJETIVO:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Investigamos las ves\u00edculas extracelulares derivadas de macr\u00f3fagos M2 y el c\u00e1ncer de colon.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>DISE\u00d1O:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Un estudio prospectivo y experimental de ves\u00edculas extracelulares derivadas de macr\u00f3fagos M2 en el c\u00e1ncer de colon.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>ESCENARIO:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Este estudio se complet\u00f3 en el Cuarto Hospital de la Universidad M\u00e9dica de Hebei.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>PACIENTES:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Pacientes con c\u00e1ncer de colon sometidos a resecci\u00f3n quir\u00fargica.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>PRINCIPALES MEDIDAS DE RESULTADO:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Se midieron el supresor de la se\u00f1alizaci\u00f3n de citoquinas 3, miR-501-3p, SETD7 y la ADN metiltransferasa 1 en muestras de c\u00e1ncer de colon. M\u00faltiples experimentos determinaron la afinidad de uni\u00f3n del supresor de la se\u00f1alizaci\u00f3n de citoquinas 3, de miR-501-3p, de SETD7 y de la ADN metiltransferasa 1. Los macr\u00f3fagos M2 se cultivaron a partir de macr\u00f3fagos M0 aislados de c\u00e9lulas mononucleares de sangre perif\u00e9rica de donantes sanos y se polarizaron para producir ves\u00edculas extracelulares. Las pruebas de ganancia o p\u00e9rdida de funci\u00f3n utilizando c\u00e9lulas de c\u00e1ncer de colon y ves\u00edculas extracelulares derivadas de macr\u00f3fagos M2 revelaron procesos biol\u00f3gicos celulares. Finalmente, se crearon modelos animales para probar c\u00f3mo miR-501-3p de ves\u00edculas extracelulares M2 afecta el crecimiento tumoral a trav\u00e9s del SETD7\/ADN metiltransferasa 1\/supresor de la se\u00f1alizaci\u00f3n de citocinas 3.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>RESULTADOS:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>El c\u00e1ncer de colon aument\u00f3 el miR-501-3p y la ADN metiltransferasa 1 y regul\u00f3 negativamente el supresor de la se\u00f1alizaci\u00f3n de citoquinas 3 y SETD7. miR-151-3p inhibi\u00f3 SETD7, regulando positivamente la ADN metiltransferasa 1. El aumento de la metilaci\u00f3n del promotor por la ADN metiltransferasa 1 produjo disminuci\u00f3n de la expresi\u00f3n del supresor de se\u00f1alizaci\u00f3n de citocinas 3. Los M2-EV con miR-501-3p regularon el eje SETD7\/ADN metiltransferasa 1\/supresor de la se\u00f1alizaci\u00f3n de citocinas 3 para inducir apoptosis y crecimiento, invasi\u00f3n y migraci\u00f3n de c\u00e9lulas de c\u00e1ncer de colon. El miR-501-3p administrado por M2-EV tambi\u00e9n regul\u00f3 el eje SETD7\/ADN metiltransferasa 1\/supresor de la se\u00f1alizaci\u00f3n de citocinas 3 para promover el crecimiento tumoral en animales.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>LIMITACIONES:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Se necesita m\u00e1s investigaci\u00f3n en la aplicaci\u00f3n cl\u00ednica de ves\u00edculas extracelulares derivadas de macr\u00f3fagos M2 que contienen miR-501-3p como biomarcador de c\u00e1ncer de colon.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>CONCLUSIONES:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Las ves\u00edculas extracelulares derivadas de macr\u00f3fagos M2 con miR-501-3p regulan el eje SETD7\/ADN metiltransferasa 1\/supresor de la se\u00f1alizaci\u00f3n de citocinas 3 para promover el c\u00e1ncer de colon. <jats:italic toggle=\"yes\">(Traducci\u00f3n\u2014Dr. Felipe Bellolio<\/jats:italic>)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dcr.0000000000002986","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T16:01:33Z","timestamp":1694448093000},"page":"e1234-e1245","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["M2 Macrophage-Derived Extracellular Vesicles Containing MicroRNA-501-3p Promote Colon Cancer Progression Through the SETD7\/DNMT1\/SOCS3 Axis"],"prefix":"10.1097","volume":"66","author":[{"given":"Yuanyi","family":"Ding","sequence":"first","affiliation":[{"name":"The Second Department of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Niu","sequence":"additional","affiliation":[{"name":"The Second Department of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Second Department of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochuan","family":"Zheng","sequence":"additional","affiliation":[{"name":"The Second Department of General Surgery, Fengning Manchu Autonomous County Hospital, Chengde, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youqiang","family":"Liu","sequence":"additional","affiliation":[{"name":"The Second Department of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Second Department of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhui","family":"Li","sequence":"additional","affiliation":[{"name":"The Second Department of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4412-6337","authenticated-orcid":false,"given":"Bin","family":"Yu","sequence":"additional","affiliation":[{"name":"The Second Department of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,11]]},"reference":[{"key":"R1-20250505","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1021\/acsnano.7b08499","article-title":"Silencing of intestinal glycoprotein CD98 by orally targeted nanoparticles enhances chemosensitization of colon cancer.","volume":"12","author":"Xiao","year":"2018","journal-title":"ACS Nano"},{"key":"R2-20250505","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/med.21809","article-title":"Trends in targeted delivery of nanomaterials in colon cancer diagnosis and treatment.","volume":"42","author":"Khan","year":"2022","journal-title":"Med Res Rev"},{"key":"R3-20250505","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/hep.28838","article-title":"Extracellular vesicles released by hepatocytes from gastric infusion model of alcoholic liver disease contain a microRNA barcode that can be detected in blood.","volume":"65","author":"Eguchi","year":"2017","journal-title":"Hepatology"},{"key":"R4-20250505","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.7150\/ijbs.69405","article-title":"M2 macrophage derived extracellular vesicle-mediated transfer of MiR-186-5p promotes colon cancer progression by targeting DLC1.","volume":"18","author":"Guo","year":"2022","journal-title":"Int J Biol Sci"},{"key":"R5-20250505","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/1871530320666200825184924","article-title":"Role of microRNAs in the progression and metastasis of colon cancer.","volume":"21","author":"Sampath","year":"2021","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"R6-20250505","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1159\/000445600","article-title":"A function variant at miR-501 alters susceptibility to hepatocellular carcinoma in a Chinese Han population.","volume":"38","author":"Liu","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"R7-20250505","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cbi.2018.02.024","article-title":"miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD.","volume":"285","author":"Sanches","year":"2018","journal-title":"Chem Biol Interact"},{"key":"R8-20250505","doi-asserted-by":"crossref","first-page":"15159","DOI":"10.18632\/oncotarget.14768","article-title":"The prognostic relevance of primary tumor location in patients undergoing resection for pancreatic ductal adenocarcinoma.","volume":"8","author":"Ling","year":"2017","journal-title":"Oncotarget"},{"key":"R9-20250505","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.it.2009.07.001","article-title":"SOCS1 and SOCS3 in the control of CNS immunity.","volume":"30","author":"Baker","year":"2009","journal-title":"Trends Immunol"},{"key":"R10-20250505","doi-asserted-by":"crossref","first-page":"e6420","DOI":"10.1097\/MD.0000000000006420","article-title":"The prognostic role of BORIS and SOCS3 in human hepatocellular carcinoma.","volume":"96","author":"Zhao","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R11-20250505","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.2147\/CMAR.S281925","article-title":"The combination therapy of fluorouracil and oxaliplatin suppress the progression of colon cancer through miR-183-5p\/SOCS3 axis and downregulating PD-L1.","volume":"13","author":"Tu","year":"2021","journal-title":"Cancer Manag Res"},{"key":"R12-20250505","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1002\/jcp.30078","article-title":"DNMT1 deregulation of SOCS3 axis drives cardiac fibroblast activation in diabetic cardiac fibrosis.","volume":"236","author":"Tao","year":"2021","journal-title":"J Cell Physiol"},{"key":"R13-20250505","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41417-018-0057-7","article-title":"Downregulation of miR-152 contributes to DNMT1-mediated silencing of SOCS3\/SHP-1 in non-Hodgkin lymphoma.","volume":"26","author":"Wang","year":"2019","journal-title":"Cancer Gene Ther"},{"key":"R14-20250505","doi-asserted-by":"crossref","first-page":"9517","DOI":"10.2147\/CMAR.S229726","article-title":"5-Aza-CdR regulates RASSF1A by inhibiting DNMT1 to affect colon cancer cell proliferation, migration and apoptosis.","volume":"11","author":"Chen","year":"2019","journal-title":"Cancer Manag Res"},{"key":"R15-20250505","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1073\/pnas.0810362106","article-title":"Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells.","volume":"106","author":"Esteve","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R16-20250505","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.bbrc.2020.03.017","article-title":"KMT Set7\/9 is a new regulator of Sam68 STAR-protein.","volume":"525","author":"Vasileva","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"R17-20250505","doi-asserted-by":"crossref","first-page":"14549","DOI":"10.1111\/jcmm.16083","article-title":"Farnesoid X receptor activation induces antitumour activity in colorectal cancer by suppressing JAK2\/STAT3 signalling via transactivation of SOCS3 gene.","volume":"24","author":"Li","year":"2020","journal-title":"J Cell Mol Med"},{"key":"R18-20250505","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3892\/or.2013.2858","article-title":"Activation of the JAK-STAT3 pathway is associated with the growth of colorectal carcinoma cells.","volume":"31","author":"Wei","year":"2014","journal-title":"Oncol Rep"},{"key":"R19-20250505","first-page":"511","article-title":"Rewarming and cardiac surgery: a review.","volume":"17","author":"Phillips","year":"1988","journal-title":"Heart Lung"},{"key":"R20-20250505","first-page":"602","article-title":"SET7 interacts with HDAC6 and suppresses the development of colon cancer through inactivation of HDAC6.","volume":"12","author":"Zhang","year":"2020","journal-title":"Am J Transl Res"},{"key":"R21-20250505","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12964-018-0229-y","article-title":"Effect of colorectal cancer-derived extracellular vesicles on the immunophenotype and cytokine secretion profile of monocytes and macrophages.","volume":"16","author":"Popena","year":"2018","journal-title":"Cell Commun Signal"},{"key":"R22-20250505","doi-asserted-by":"crossref","first-page":"107138","DOI":"10.1016\/j.intimp.2020.107138","article-title":"M1 macrophages-derived extracellular vesicles elevate microRNA-185-3p to aggravate the development of atherosclerosis in ApoE(-\/-) mice by inhibiting small mothers against decapentaplegic 7.","volume":"90","author":"Li","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"R23-20250505","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","article-title":"MicroRNAs in cancer.","volume":"9","author":"Di Leva","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"R24-20250505","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1038\/sj.onc.1210286","article-title":"Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon.","volume":"26","author":"Rigby","year":"2007","journal-title":"Oncogene"},{"key":"R25-20250505","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/carcin\/bgs214","article-title":"IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer.","volume":"33","author":"Li","year":"2012","journal-title":"Carcinogenesis"},{"key":"R26-20250505","doi-asserted-by":"crossref","first-page":"6663782","DOI":"10.1155\/2021\/6663782","article-title":"Fenofibrate exerts antitumor effects in colon cancer via regulation of DNMT1 and CDKN2A.","volume":"2021","author":"Kong","year":"2021","journal-title":"PPAR Res"},{"key":"R27-20250505","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.gastro.2019.05.057","article-title":"Intestinal PPARalpha protects against colon carcinogenesis via regulation of methyltransferases DNMT1 and PRMT6.","volume":"157","author":"Luo","year":"2019","journal-title":"Gastroenterology"},{"key":"R28-20250505","first-page":"3783","article-title":"Resveratrol induces p53 in colorectal cancer through SET7\/9.","volume":"17","author":"Liu","year":"2019","journal-title":"Oncol Lett"},{"key":"R29-20250505","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ebiom.2018.08.042","article-title":"Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients.","volume":"35","author":"Ji","year":"2018","journal-title":"EBioMedicine"},{"key":"R30-20250505","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s13046-019-1313-x","article-title":"Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-beta signaling pathway.","volume":"38","author":"Yin","year":"2019","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Diseases of the Colon &amp; Rectum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DCR.0000000000002986","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T23:21:01Z","timestamp":1746487261000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DCR.0000000000002986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/dcr.0000000000002986","relation":{},"ISSN":["0012-3706"],"issn-type":[{"value":"0012-3706","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,11]]}}}